Correction: Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma

Bing Liu, Wei Tao, Xuantong Zhou, Li‑Di Xu, Yanrui Luo, Xin Yang, Qingjie Min, Miao Huang, Yuge Zhu, Xinrun Cui, Yaqi Wang, Tongyang Gong, Enli Zhang, Yu S. Huang, Weizhi Chen, Shi Yan, Nan Wu

Open source

DOI
10.1186/s12943-026-02802-7
Published
9
Container
Molecular Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02802-7,
  title = {Correction: Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma},
  author = {Bing Liu and Wei Tao and Xuantong Zhou and Li‑Di Xu and Yanrui Luo and Xin Yang and Qingjie Min and Miao Huang and Yuge Zhu and Xinrun Cui and Yaqi Wang and Tongyang Gong and Enli Zhang and Yu S. Huang and Weizhi Chen and Shi Yan and Nan Wu},
  year = {2026},
  journal = {Molecular Cancer},
  doi = {10.1186/s12943-026-02802-7},
  url = {https://doi.org/10.1186/s12943-026-02802-7}
}

RIS

TY  - JOUR
TI  - Correction: Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma
AU  - Bing Liu
AU  - Wei Tao
AU  - Xuantong Zhou
AU  - Li‑Di Xu
AU  - Yanrui Luo
AU  - Xin Yang
AU  - Qingjie Min
AU  - Miao Huang
AU  - Yuge Zhu
AU  - Xinrun Cui
AU  - Yaqi Wang
AU  - Tongyang Gong
AU  - Enli Zhang
AU  - Yu S. Huang
AU  - Weizhi Chen
AU  - Shi Yan
AU  - Nan Wu
PY  - 2026
JO  - Molecular Cancer
DO  - 10.1186/s12943-026-02802-7
UR  - https://doi.org/10.1186/s12943-026-02802-7
ER  - 

APA

Liu, B., Tao, W., Zhou, X., Xu, L., Luo, Y., Yang, X., Min, Q., Huang, M., Zhu, Y., Cui, X., Wang, Y., Gong, T., Zhang, E., Huang, Y. S., Chen, W., Yan, S., & Wu, N. (2026). Correction: Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma. Molecular Cancer. https://doi.org/10.1186/s12943-026-02802-7

Source records